tradingkey.logo
tradingkey.logo
Search

Elicio Therapeutics Inc

ELTX
Add to Watchlist
2.800USD
-0.110-3.78%
Close 07-31 16:00ETQuotes delayed by 15 min
49.84MMarket Cap
LossP/E TTM

ELTX Financials

See Elicio Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Elicio Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.65/-0.47
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.58
39.24%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
24.99%-0.65
51.49%-0.50
56.45%-0.60
-2.66%-0.66
24.81%-0.87
42.04%-1.03
-9.00%-1.39
73.72%-0.64
56.82%-1.15
17.24%-1.77
---1.27
---2.44
---2.67
---2.14
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
-100.00%0.00
20.93%653.00K
344.20%1.65M
5551.63%25.94M
--1.46M
-25.93%540.00K
Net Profit
-5.48%-11.82M
44.89%-7.72M
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
Debt to assets ratio
--41.76%
-48.84%36.37%
-33.49%34.37%
--31.62%
--0.00%
--71.10%
--51.67%
----
----
----
----
----
--0.00%
--0.45%
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
-100.00%0.00
20.93%653.00K
344.20%1.65M
5551.63%25.94M
--1.46M
-25.93%540.00K
Operating profit
1.25%-10.60M
34.39%-8.84M
22.23%-8.04M
7.63%-10.09M
-4.83%-10.74M
-43.48%-13.48M
3.96%-10.34M
-40.47%-10.92M
-31.21%-10.24M
-140.51%-9.39M
-72.25%-10.77M
13.92%-7.78M
46.12%-7.80M
-126.68%-3.91M
60.32%-6.25M
50.48%-9.04M
27.35%-14.48M
205.66%14.63M
---15.76M
-5.65%-18.24M
Net Profit
-5.48%-11.82M
44.89%-7.72M
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
Current assets
-22.62%16.20M
-6.68%19.31M
-29.96%21.46M
237.84%22.60M
48.16%20.93M
26.58%20.69M
53.76%30.65M
-74.49%6.69M
-65.22%14.13M
-68.21%16.35M
-64.84%19.93M
-60.20%26.23M
-46.71%40.63M
-43.64%51.43M
-45.71%56.68M
-44.96%65.89M
-42.89%76.24M
115.73%91.25M
502.38%104.39M
--119.70M
Total current liabilities
-36.66%7.23M
-29.62%8.11M
-27.77%6.51M
30.82%9.92M
91.78%11.41M
17.99%11.52M
-21.47%9.02M
-0.16%7.58M
193.01%5.95M
53.34%9.77M
40.38%11.49M
-2.35%7.60M
-80.44%2.03M
-43.62%6.37M
-54.41%8.18M
-62.09%7.78M
-38.80%10.38M
-89.49%11.30M
-77.92%17.95M
--20.52M
Total assets
-19.38%22.69M
-8.22%25.86M
-26.32%28.28M
87.48%29.53M
14.97%28.14M
3.80%28.18M
23.88%38.39M
-58.13%15.75M
-41.39%24.48M
-48.58%27.15M
-49.46%30.99M
-46.88%37.62M
-48.60%41.77M
-45.30%52.79M
-44.23%61.32M
-43.51%70.81M
-41.63%81.26M
103.84%96.51M
383.38%109.94M
--125.36M
Total liabilities
25.40%24.13M
-38.65%24.23M
-57.35%24.47M
59.14%27.69M
-1.89%19.24M
150.36%39.49M
224.13%57.37M
23.75%17.40M
833.37%19.61M
74.91%15.77M
59.38%17.70M
27.22%14.06M
-85.05%2.10M
-39.90%9.02M
-75.55%11.11M
-77.05%11.05M
-69.94%14.06M
-89.11%15.01M
-47.14%45.43M
--48.17M
Total equity
-116.14%-1.44M
114.46%1.64M
120.10%3.82M
211.02%1.83M
82.83%8.90M
-199.46%-11.31M
-242.90%-18.99M
-107.01%-1.65M
-87.72%4.87M
-74.02%11.37M
-73.54%13.29M
-60.58%23.56M
-40.97%39.67M
-46.30%43.77M
-22.17%50.21M
-22.58%59.76M
-27.30%67.20M
190.11%81.51M
202.09%64.51M
--77.19M
Net operating income
-15.08%-11.64M
22.27%-6.80M
-52.41%-11.09M
-0.25%-8.95M
16.52%-10.12M
11.64%-8.74M
-40.32%-7.27M
6.37%-8.93M
-48.94%-12.12M
-123.59%-9.90M
38.33%-5.18M
3.74%-9.54M
48.00%-8.14M
69.18%-4.43M
44.69%-8.41M
5.94%-9.90M
-24.72%-15.65M
-169.75%-14.36M
---15.20M
---10.53M
Net investment
----
64.44%-16.00K
--0.00
100.00%0.00
-100.00%0.00
---45.00K
100.00%0.00
-100.42%-42.00K
117.65%3.00K
--0.00
---45.00K
--10.01M
---17.00K
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
-260.00%-36.00K
---61.00K
---244.00K
Net financing
-22.28%8.03M
2042.29%4.86M
-68.88%9.57M
3675.95%11.93M
-6.31%10.33M
-96.76%227.00K
52025.42%30.75M
-99.09%316.00K
9.80%11.02M
46780.00%7.00M
447.06%59.00K
248814.29%34.82M
71814.29%10.04M
-103.71%-15.00K
-102.43%-17.00K
99.41%-14.00K
-100.01%-14.00K
100.00%404.00K
--699.00K
---2.38M

FAQs

What are the current assets of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its current assets were 19.31M, with a year-on-year change of -6.68.

What are the total assets of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its total assets of Elicio Therapeutics Inc were 25.86M, with a year-on-year change of -8.22.

What are the total liabilities of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its total liabilities of Elicio Therapeutics Inc were 24.23M, with a year-on-year change of -38.65.

What is the total equity of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its total equity of Elicio Therapeutics Inc was 1.64M, with a year-on-year change of 114.46.

What is the net operating income of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its net operating income of Elicio Therapeutics Inc was -37.71M, with a year-on-year change of 16.17.

What is the net investment of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its net investment of Elicio Therapeutics Inc was -16.00K, with a year-on-year change of 80.95.

What is the net financing of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its net financing of Elicio Therapeutics Inc was 36.70M, with a year-on-year change of -13.29.

What is the Earnings Per Share (EPS) of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.58, with a year-on-year change of 39.24.

What is the net income of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its net income was -39.57M, with a year-on-year change of 23.75.

What is the debt-to-asset ratio of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 36.37, with a year-on-year change of -48.84.

What is the Return on Assets (ROA) of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -146.45, with a year-on-year change of 21.94.

What is the operating profit of Elicio Therapeutics Inc?

According to Elicio Therapeutics Inc's FY2025 earnings report, its operating profit was -37.71M, with a year-on-year change of 16.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.